Forma Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Forma Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile


  • Products Id :- GDPH137978D
  • |
  • Pages: 36
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Forma Therapeutics Inc (Forma) is a drug discovery and development company that discovers and develops new transformative cancer therapeutics. The company develops technologies to identify the initial molecules that provide drug discovery program. It offers research in the areas of tumor metabolism, epigenetics, protein homeostasis and protein-protein interactions. FORMA's drug development process includes computational and medicinal chemistry, parallel synthesis, X-ray crystallography, and relevant biology studies. The company collaborates with biotechnology companies, pharmaceuticals and biomedicine companies and research institutes for its research and development activities. It operates offices in Watertown and Branford, the US. FORMA is headquartered in Watertown, Massachusetts, the US.

Forma Therapeutics Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Forma Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Forma Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Forma Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Forma Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Forma Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Forma Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 11

Venture Financing 11

Forma Therapeutics Raises USD 10 Million In Venture Financing 11

Partnerships 12

Ubiquigent Enters into Development Agreement with Forma Therapeutics 12

Forma Therapeutics Enters into Agreement with Arpeggio Biosciences 13

Celgene Enters into Agreement with Forma Therapeutics 14

ZoBio and Domainex Enter into Agreement with Forma Therapeutics 15

Forma Therapeutics Expands Discovery Agreement with Cancer Research Technology 16

Forma Therapeutics Partners With Celgene 17

Forma Therapeutics Enters Into Agreement With Celgene 18

Forma Therapeutics Enters Into Co-Development Agreement With TGen Drug Development 20

FORMA Therapeutics Enters Into Co-Development Agreement With Janssen Biotech 21

FORMA Therapeutics Enters Into R&D Agreement With Boehringer Ingelheim 22

Licensing Agreements 23

Forma Therapeutics and HitGen Enter into Licensing Agreement 23

Forma Therapeutics Enters into Licensing Agreement with University of Oxford 24

Forma Therapeutics Enters Into Licensing Agreement With Netherlands Cancer Institute 25

Janssen Biotech Exercises Option For Licensing Agreement With Forma Therapeutics 26

Moffitt Cancer Center Enters into Option for Licensing Agreement with Forma Therapeutics 27

Forma Therapeutics Inc-Key Competitors 28

Forma Therapeutics Inc-Key Employees 29

Forma Therapeutics Inc-Locations And Subsidiaries 30

Head Office 30

Other Locations & Subsidiaries 30

Recent Developments 31

Corporate Communications 31

Apr 09, 2018: FORMA Therapeutics Appoints Tim Clackson As Board Director 31

Nov 14, 2017: FORMA Therapeutics Appoints Christine Bellon, Ph.D., J.D., General Counsel and Corporate Secretary 32

Government and Public Interest 33

Feb 21, 2017: FORMA Therapeutics Awarded Grant from Michael J. Fox Foundation for Parkinson's Research 33

Product News 34

Apr 05, 2018: FORMA Therapeutics Achieves Key Objective in Collaboration with Celgene to Advance a Novel Protein Homeostasis Oncology/Immuno-Oncology Program 34

Other Significant Developments 35

Mar 13, 2017: FORMA Therapeutics Announces Achievement of First Clinical Development Milestone in Partnership with Boehringer Ingelheim 35

Appendix 36

Methodology 36

About GlobalData 36

Contact Us 36

Disclaimer 36

List of Figures

Forma Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Forma Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Forma Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Forma Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Forma Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Forma Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Forma Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Forma Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

List of Tables

Forma Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts 2

Forma Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Forma Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Forma Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Forma Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 8

Forma Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Forma Therapeutics Raises USD 10 Million In Venture Financing 11

Ubiquigent Enters into Development Agreement with Forma Therapeutics 12

Forma Therapeutics Enters into Agreement with Arpeggio Biosciences 13

Celgene Enters into Agreement with Forma Therapeutics 14

ZoBio and Domainex Enter into Agreement with Forma Therapeutics 15

Forma Therapeutics Expands Discovery Agreement with Cancer Research Technology 16

Forma Therapeutics Partners With Celgene 17

Forma Therapeutics Enters Into Agreement With Celgene 18

Forma Therapeutics Enters Into Co-Development Agreement With TGen Drug Development 20

FORMA Therapeutics Enters Into Co-Development Agreement With Janssen Biotech 21

FORMA Therapeutics Enters Into R&D Agreement With Boehringer Ingelheim 22

Forma Therapeutics and HitGen Enter into Licensing Agreement 23

Forma Therapeutics Enters into Licensing Agreement with University of Oxford 24

Forma Therapeutics Enters Into Licensing Agreement With Netherlands Cancer Institute 25

Janssen Biotech Exercises Option For Licensing Agreement With Forma Therapeutics 26

Moffitt Cancer Center Enters into Option for Licensing Agreement with Forma Therapeutics 27

Forma Therapeutics Inc, Key Competitors 28

Forma Therapeutics Inc, Key Employees 29

Forma Therapeutics Inc, Other Locations 30

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

select a license
Single User License
USD 250 INR 17815
Site License
USD 500 INR 35630
Corporate User License
USD 750 INR 53445

NEWSLETTER BY CATEGORY




Testimonials

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com